Primary Objective: To assess the impact of RYGB on gallbladder function (during a follow-up interval of 1 year). We will assess the fasting volume, the ejection fraction and the residual volume of the gallbladder. In addition, we will compare serum…
ID
Source
Brief title
Condition
- Gastrointestinal motility and defaecation conditions
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Ultrasonography measured gallbladder functions after RYGB. Gallbladder function
is assessed using the measurement of ejection fraction, residual volume and
fasting volume after an overnight fast.
Secondary outcome
Secondary study parameters/endpoints (if applicable)
1. Incidence of biliary symptoms
2. Incidence of bile sludge
3. Incidence of symptomatic cholecystolithiasis
4. Serum cholecystokinin levels
Other study parameters
Patient characteristics:
- Age
- Gender
- Ethnicity
- Comorbidities
- BMI
- Weight loss
- Excess weight loss
Background summary
Obesity is a growing problem with many adverse effects on human health. The
Roux-en-Y Gastric Bypass has been an effective method to treat obesity. The
long-term mortality decreases in the treated population. The incidence of
gallbladder pathology is increasing after a RYGB procedure . Changes in
cholesterol saturation of the bile, increased crystallizing factors, and a
deterioration of the gall bladder function are likely to be the cause of this
increase in gallbladder pathology. Several studies have been conducted on this
subject, but several questions remain.
Study objective
Primary Objective: To assess the impact of RYGB on gallbladder function (during
a follow-up interval of 1 year). We will assess the fasting volume, the
ejection fraction and the residual volume of the gallbladder. In addition, we
will compare serum cholecystokinin levels before and after RYGB.
Hypothesis: We expect that gallbladder function will decrease (decreased
ejection fraction, increased residual volume and fasting volume) during
follow-up after RYGB.
Secondary Objective(s):
1 To evaluate the number of patients that will develop sludge or gallstones
after a RYGB
2 To determine in which time-frame most gallstones will develop
3 To assess if gallstones development is correlated with a change in
gallbladder function
4 To assess if the amount of EWL correlates with a change gallbladder function
5 To define causes of impaired function, eg is this CCK mediated or is nervus
vagus damage contributing.
6 To predict gallstone development in the RYGB patient population
Study design
An observational case-control study will be conducted at the Maasstad Hospital,
Rotterdam. Patients will be included from the bariatric outpatient clinic
during their intake visits. The gallbladder function of the subjects will be
assessed two weeks prior to and 6 and 12 months after their RYGB. Together with
the ultrasonographic assessment serum cholecystokinin levels will be determined.
After 12 months of follow-up data collection will be completed and statistical
analysis of the data will be conducted.
Study burden and risks
The burden on the subject is low. The ultrasound will take place in the morning
so the fasting period will be an overnight fast. The test meal carries no risk.
The venous puncture is common practice, which hardly involves any risks.
Maasstadweg 21
Rotterdam 3079DZ
NL
Maasstadweg 21
Rotterdam 3079DZ
NL
Listed location countries
Age
Inclusion criteria
Eligible patients meet the current bariatric surgery criteria used in our clinic, in accordance with IFSO criteria.
The age of the patient is 18-65 years. BMI >= 40 kg/m2 or BMI >=35 kg/m2; with serious comorbidities related to obesity such as diabetes mellitus, OSAS and arthrosis.
Exclusion criteria
-Patients with previous (laparoscopic) cholecystectomy will be excluded.
-Patients with presenting with biliary symptoms or gallstones at time of RYGB will be excluded.
-Patients with a different intervention than a Roux-en-Y Gastric Bypass will be excluded (eg. Gastric sleeve, gastric band, etc.)
-Ursodeoxycholic acid usage.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL48439.101.14 |